Decreased core muscle size is associated with worse patient survival following esophagectomy for cancer

Diseases of the Esophagus

Volumn 26, Issue 7, 2013, Pages 716-722

  Sheetz, K H ^a   Zhao, L ^a   Holcombe, S A ^a   Wang, S C ^a   Reddy, R M ^a   Lin, J ^a   Orringer, M B ^a   Chang, A C ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Esophageal cancer; Esophageal surgery; Risk stratification

Indexed keywords

ADULT; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; CANCER STAGING; CHYLOTHORAX; COMPUTER ASSISTED TOMOGRAPHY; CORE MUSCLE SIZE; DISEASE FREE SURVIVAL; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; GASTROINTESTINAL INFECTION; HEART ATRIUM FIBRILLATION; HUMAN; LUMBAR VERTEBRA; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MUSCLE MASS; MUSCULOSKELETAL SYSTEM PARAMETERS; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; VOCAL CORD PARALYSIS;

ESOPHAGEAL CANCER; ESOPHAGEAL SURGERY; RISK STRATIFICATION;

ADENOCARCINOMA; AGED; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; ORGAN SIZE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PSOAS MUSCLES; RETROSPECTIVE STUDIES; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84884725124     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/dote.12020     Document Type: Article

References (29)

1. Deyo R A, Mirza S K, Martin B I, Kreuter W, Goodman D C, Jarvik J G. Trends, major medical complications, and charges associated with surgery for lumbar spinal stenosis in older adults. JAMA 2010; 303: 1259-1265.
2. Zingmond D, Maggard M, O'Connell J, Liu J, Etzioni D, Ko C. What predicts serious complications in colorectal cancer resection? Am Surg 2003; 69: 969-974.
3. Hannan E L, Racz M J, Walford G etal. Predictors of readmission for complications of coronary artery bypass graft surgery. JAMA 2003; 290: 773-780.
4. Nallamothu B K, Rogers M A, Saint S etal. Skilled care requirements for elderly patients after coronary artery bypass grafting. J Am Geriatr Soc 2005; 53: 1133-1137.
5. Nguyen-Oghalai T U, Kuo Y F, Zhang D D, Graham J E, Goodwin J S, Ottenbacher K J. Discharge setting for patients with hip fracture: trends from 2001 to 2005. J Am Geriatr Soc 2008; 56: 1063-1068.
6. Pohl H, Welch H G. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst 2005; 97: 142-146.
7. Bailey S H, Bull D A, Harpole D H etal. Outcomes after esophagectomy: a ten-year prospective cohort. Ann Thorac Surg 2003; 75: 217-222.
8. Connors R C, Reuben B C, Neumayer L A, Bull D A. Comparing outcomes after transthoracic and transhiatal esophagectomy: a 5-year prospective cohort of 17, 395 patients. J Am Coll Surg 2007; 205: 735-740.
9. Orringer M B, Marshall B, Chang A C, Lee J, Pickens A, Lau C L. Two thousand transhiatal esophagectomies: changing trends, lessons learned. Ann Surg 2007; 246: 363-372.
10. Englesbe M J, Patel S P, He K etal. Sarcopenia and mortality after liver transplantation. J Am Coll Surg 2010; 211: 271-278.
11. Lee J S-J, He K, Harbaugh C M etal. Frailty, core muscle size, and mortality in patients undergoing open abdominal aortic aneurysm repair. J Vasc Surg 2011; 53: 912-917.
12. Greene F L, Page D L, Fleming I D, Balch C M, (eds). AJCC Cancer Staging Manual, 6th edn. New York: Springer-Verlag, 2002.
13. Cawthon P M, Fox K M, Gandra S R etal. Do muscle mass, muscle density, strength, and physical function similarly influence risk of hospitalization in older adults? J Am Geriatr Soc 2009; 57: 1411-1419.
14. Pahor M, Manini T, Cesari M. Sarcopenia: clinical evaluation, biological markers and other evaluation tools. J Nutr Health Aging 2009; 13: 724-728.
15. Cox D R. Regression models and life-tables. J R Stat Soc B 1972; 34: 187-220.
16. von Elm E, Altman D G, Egger M, Pocock S J, Gøtzsche P C, Vandenbroucke J P. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007; 370 (9596): 1453-1457.
17. Livingston E H, Cao J. Procedure volume as a predictor of surgical outcomes. JAMA 2010; 304: 95-97.
18. Lagarde S M, Reitsma J B, Maris A-K D etal. Preoperative prediction of the occurrence and severity of complications after esophagectomy for cancer with use of a nomogram. Ann Thorac Surg 2008; 85: 1938-1945.
19. Steyerberg E W, Neville B A, Koppert L B etal. Surgical mortality in patients with esophageal cancer: development and validation of a simple risk score. J Clin Oncol 2006; 24: 4277-4284.
20. Tekkis P P, McCulloch P, Poloniecki J D, Prytherch D R, Kessaris N, Steger A C. Risk-adjusted prediction of operative mortality in oesophagogastric surgery with O-POSSUM. Br J Surg 2004; 91: 288-295.
21. Bartels H, Stein H J, Siewert J R. Preoperative risk analysis and postoperative mortality of oesophagectomy for resectable oesophageal cancer. Br J Surg 1998; 85: 840-844.
22. Lagarde S M, Maris A K, de Castro S M, Busch O R, Obertop H, van Lanschot J J. Evaluation of O-POSSUM in predicting in-hospital mortality after resection for oesophageal cancer. Br J Surg 2007; 94: 1521-1526.
23. Internullo E, Moons J, Nafteux P etal. Outcome after esophagectomy for cancer of the esophagus and GEJ in patients aged over 75 years. Eur J Cardiothorac Surg 2008; 33: 1096-1104.
24. Makary M A, Segev D L, Pronovost P J etal. Frailty as a predictor of surgical outcomes in older patients. J Am Coll Surg 2010; 210: 901-908.
25. Fried L P, Tangen C M, Walston J etal. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001; 56: M146-157.
26. Marcell T J. Sarcopenia: causes, consequences, and preventions. J Gerontol A Biol Sci Med Sci 2003; 58: M911-916.
27. Verdijk L B, Gleeson B G, Jonkers R A etal. Skeletal muscle hypertrophy following resistance training is accompanied by a fiber type-specific increase in satellite cell content in elderly men. J Gerontol A Biol Sci Med Sci 2009; 64: 332-339.
28. Prado C M M, Baracos V E, McCargar L J etal. Body composition as an independent determinant of 5-fluorouracil-based chemotherapy toxicity. Clin Cancer Res 2007; 13: 3264-3268.
29. Prado C M M, Baracos V E, McCargar L J etal. Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res 2009; 15: 2920-2926.